SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038057
Filing Date
2024-03-28
Accepted
2024-03-28 16:15:41
Documents
88
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K asmb-20231231.htm   iXBRL 10-K 2330515
2 EX-3.1 asmb-ex3_1.htm EX-3.1 40236
3 EX-4.2 asmb-ex4_2.htm EX-4.2 20832
4 EX-10.11 asmb-ex10_11.htm EX-10.11 114102
5 EX-10.12 asmb-ex10_12.htm EX-10.12 105862
6 EX-21.1 asmb-ex21_1.htm EX-21.1 6812
7 EX-23.1 asmb-ex23_1.htm EX-23.1 13598
8 EX-31.1 asmb-ex31_1.htm EX-31.1 14622
9 EX-32.1 asmb-ex32_1.htm EX-32.1 7119
10 EX-97.1 asmb-ex97_1.htm EX-97.1 53100
11 GRAPHIC img55580476_0.jpg GRAPHIC 31604
  Complete submission text file 0000950170-24-038057.txt   11117470

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20231231.xsd EX-101.SCH 1575736
92 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20231231_htm.xml XML 2035739
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35005 | Film No.: 24799149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)